There are an estimated 200,000 severe ADRs in Canada each year, though it is estimated that 95% of ADRs are not reported. They cost the Canadian healthcare system between $13.7 and $17.7 billion each year and kill up to 22,000 Canadians each year. Over 5,000 of these are Canadian children. ADR Canada is working to prevent this.

About

About Adverse Drug Reaction Canada  ADR Canada is a national, non-partisan, not-for-profit organization that educates and raises awareness on how we can prevent adverse drug reactions in Canada. We bring together patients, families, policy-makers, scientists, researchers, health care providers and academics to develop policy solutions and advance research to prevent adverse drug reactions across Canada. Mission … Continue reading About

Policies

ADR Canada advocates for three policies which will lead Canada on the path to preventing adverse drug reactions: 1. Establishing a national mandatory database to record and monitor all adverse drug reactions. 2. Establishing publicly funded genetic screening to identify gene variants in individuals that can lead to adverse drug reactions. 3. Establishing a centralized… Continue reading Policies

Recent ADR News

Routine DNA tests will put NHS at the ‘forefront of medicine,’ Ian Sample, July 3, 2018, The Guardian. DNA on drugs: How genetic tests could make prescriptions more precise, Carolyn Abraham, March 16, 2018, The Globe and Mail. Jane Philpott moves on. Health Canada’s drug problems remain, Anne Kingston, August 28, 2017, Maclean’s Opposition stands behind… Continue reading Recent ADR News

“[Genetic testing is] going to make people healthier, it’s going to make drugs safer and it’s going to save money in the end.”

Mark Kunzli, pharmacist and UBC pharmacogenomics researcher

Each year, up to 22,000 Canadians die from an Adverse Drug Reaction.